A

Atara Biotherapeutics
D

ATRA

7.11000
USD
-0.42
(-5.58%)
مغلق
حجم التداول
1,948
الربح لكل سهم
-9
العائد الربحي
-
P/E
-0
حجم السوق
40,951,823
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ARRY
    -0.31500
    (-4.57%)
    6.58500 USD
    B
    BLUE
    -2.93000
    (-41.68%)
    4.10000 USD
    B
    BMRN
    -0.525
    (-0.76%)
    68.215 USD
    C
    CRSP
    -2.620
    (-5.19%)
    47.840 USD
    E
    EDIT
    -0.14000
    (-6.80%)
    1.92000 USD
    I
    INCY
    0.790
    (1.11%)
    72.150 USD
    L
    LGND
    -1.350
    (-1.11%)
    120.680 USD
    المزيد
الأخبار
المقالات

العنوان: Atara Biotherapeutics Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).